AMISTAD II

Acute Myocardial Infarction Study of Adenosine II. A trial evaluating adenosine as an adjunct to thrombolytic reperfusion in decreasing the size of MIs
s,
Primary endpoint
Mortality, new heart failure.

Conclusion
Somewhat helpful at higher doses but not statistically significant.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.